BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed BCDA catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:90a634d713bfab6d270d@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:BCDA P1/P2 readout (est.): CardiALLO
DESCRIPTION:Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-
 derived Mesenchymal Stem Cells\nNCT05925608 | PHASE1/PHASE2 | ACTIVE_NOT_R
 ECRUITING | sponsor: BioCardia\, Inc.\nPrimary completion date (ESTIMATED)
 \; top-line results usually follow later.\nDate precision: month (shown on
  the first day)\nTicker BCDA (confidence 0.9)\nSource: https://clinicaltri
 als.gov/study/NCT05925608\nScheduling/reference data from public records\;
  dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05925608
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
